Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Buhl

Showing results (211-220 of 270) with videos related to

Pageof 27
Sort By:
Lancet (London, England)|December 2, 1989
Systemic glutathione deficiency in symptom-free HIV-seropositive individualsR Buhl, H A Jaffe, K J Holroyd, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosolR Buhl, C Vogelmeier, M Critenden, et al.
Annals of Saudi Medicine|July 1, 1994
Hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal diseases: A seroprevalence studyS S Al-Dhahry, P N Aghanashinikar, H A Al-Marhuby, et al.
Allergy|February 1, 2005
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthmaJ Bousquet, P Cabrera, N Berkman, et al.
Transplantation Proceedings|October 1, 1992
Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseasesP N Aghanashinikar, S H al-Dhahry, H A al-Marhuby, et al.
Lancet (London, England)|March 3, 1990
Glutathione deficiency and HIVR Buhl, H A Jaffe, K J Holroyd, et al.
Pneumologie (Stuttgart, Germany)|March 6, 2008
[Trial end-point in chronic obstructive pulmonary disease (COPD): minimal clinically important difference]A Gillissen, R Buhl, P Kardos, et al.
The European Respiratory Journal|August 9, 2002
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthmaR Buhl, M Solèr, J Matz, et al.
Pulmonary Pharmacology & Therapeutics|December 8, 2007
Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary diseaseL Grönke, K M Beeh, R Cameron, et al.
Journal of Veterinary Pharmacology and Therapeutics|March 23, 2018
Effects of trimethoprim-sulfadiazine and detomidine on the function of equine K<sub>v</sub> 11.1 channels in a two-electrode voltage-clamp (TEVC) oocyte modelD S Trachsel, M A Tejada, V Groesfjeld Christensen, et al.
Pageof 27

Showing results (211-220 of 270) with videos related to

Sort By:
Pageof 27
Lancet (London, England)|December 2, 1989
Systemic glutathione deficiency in symptom-free HIV-seropositive individualsR Buhl, H A Jaffe, K J Holroyd, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosolR Buhl, C Vogelmeier, M Critenden, et al.
Annals of Saudi Medicine|July 1, 1994
Hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal diseases: A seroprevalence studyS S Al-Dhahry, P N Aghanashinikar, H A Al-Marhuby, et al.
Allergy|February 1, 2005
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthmaJ Bousquet, P Cabrera, N Berkman, et al.
Transplantation Proceedings|October 1, 1992
Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseasesP N Aghanashinikar, S H al-Dhahry, H A al-Marhuby, et al.
Lancet (London, England)|March 3, 1990
Glutathione deficiency and HIVR Buhl, H A Jaffe, K J Holroyd, et al.
Pneumologie (Stuttgart, Germany)|March 6, 2008
[Trial end-point in chronic obstructive pulmonary disease (COPD): minimal clinically important difference]A Gillissen, R Buhl, P Kardos, et al.
The European Respiratory Journal|August 9, 2002
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthmaR Buhl, M Solèr, J Matz, et al.
Pulmonary Pharmacology & Therapeutics|December 8, 2007
Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary diseaseL Grönke, K M Beeh, R Cameron, et al.
Journal of Veterinary Pharmacology and Therapeutics|March 23, 2018
Effects of trimethoprim-sulfadiazine and detomidine on the function of equine K<sub>v</sub> 11.1 channels in a two-electrode voltage-clamp (TEVC) oocyte modelD S Trachsel, M A Tejada, V Groesfjeld Christensen, et al.
Pageof 27